Urinary aHGF, IGFBP3 and OPN as diagnostic and prognostic biomarkers for prostate cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Urinary aHGF, IGFBP3 and OPN as diagnostic and prognostic biomarkers for prostate cancer
Authors
Keywords
-
Journal
Biomarkers in Medicine
Volume 7, Issue 6, Pages 831-841
Publisher
Future Medicine Ltd
Online
2013-11-23
DOI
10.2217/bmm.13.112
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fibronectin Pattern in Benign Hyperplasia and Cancer of the Prostate
- (2013) Miroslava M. Janković et al. DISEASE MARKERS
- Correlation of Plasma FL Expression with Bone Marrow Irradiation Dose
- (2013) Mary Sproull et al. PLoS One
- Plasma osteopontin as a biomarker of prostate cancer aggression: relationship to risk category and treatment response
- (2012) J W Thoms et al. BRITISH JOURNAL OF CANCER
- Urinary OPN excretion in children with glomerular proteinuria
- (2011) A Wasilewska et al. Advances in Medical Sciences
- Abnormal Expression of the ERG Transcription Factor in Prostate Cancer Cells Activates Osteopontin
- (2011) S. Flajollet et al. MOLECULAR CANCER RESEARCH
- Biomarker research in prostate cancer—towards utility, not futility
- (2011) Sheng Fei Oon et al. Nature Reviews Urology
- Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA
- (2011) S. A. Tomlins et al. Science Translational Medicine
- PSA and Beyond: The Past, Present, and Future of Investigative Biomarkers for Prostate Cancer
- (2011) Jeffrey Tosoian et al. TheScientificWorldJOURNAL
- An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression
- (2010) Jindan Yu et al. CANCER CELL
- Extracellular matrix: A gatekeeper in the transition from dormancy to metastatic growth
- (2010) Dalit Barkan et al. EUROPEAN JOURNAL OF CANCER
- Use and Assessment of PSA in Prostate Cancer
- (2010) Carl K. Gjertson et al. MEDICAL CLINICS OF NORTH AMERICA
- Urine Analysis and Protein Networking Identify Met as a Marker of Metastatic Prostate Cancer
- (2009) A. L. Russo et al. CLINICAL CANCER RESEARCH
- Unraveling Insulin-Like Growth Factor Binding Protein-3 Actions in Human Disease
- (2009) Sherryline Jogie-Brahim et al. ENDOCRINE REVIEWS
- Osteopontin induces β-catenin signaling through activation of Akt in prostate cancer cells
- (2009) Brian W. Robertson et al. EXPERIMENTAL CELL RESEARCH
- Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context
- (2009) G. Draisma et al. JNCI-Journal of the National Cancer Institute
- Predictive Value of Plasma Hepatocyte Growth Factor/Scatter Factor Levels in Patients with Clinically Localized Prostate Cancer
- (2008) A. Gupta et al. CLINICAL CANCER RESEARCH
- Non-patient related variables affecting levels of vascular endothelial growth factor in urine biospecimens
- (2008) M. J. Kirk et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Serum active hepatocyte growth factor (AHGF) in benign prostatic disease and prostate cancer
- (2008) Kenji Yasuda et al. PROSTATE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started